1. Home
  2. AOUT vs CGEN Comparison

AOUT vs CGEN Comparison

Compare AOUT & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Outdoor Brands Inc.

AOUT

American Outdoor Brands Inc.

HOLD

Current Price

$7.85

Market Cap

91.1M

Sector

Industrials

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.52

Market Cap

125.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOUT
CGEN
Founded
2020
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.1M
125.3M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
AOUT
CGEN
Price
$7.85
$1.52
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
99.1K
278.6K
Earning Date
12-09-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$207,348,000.00
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.08
$231.15
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$6.26
$1.13
52 Week High
$17.91
$2.66

Technical Indicators

Market Signals
Indicator
AOUT
CGEN
Relative Strength Index (RSI) 66.88 43.59
Support Level $7.04 $1.47
Resistance Level $8.16 $1.72
Average True Range (ATR) 0.37 0.09
MACD 0.16 0.01
Stochastic Oscillator 82.12 24.01

Price Performance

Historical Comparison
AOUT
CGEN

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: